Clinical Immunology and Rheumatology, Nizams Institute of Medical Sciences (NIMS), Hyderabad, India
Volume 33, Issue 4, December 2022
Sign in to download the Issue in PDF format.
1853501599
Mediterr J Rheumatol 2022;33(4):449-52
Article Links
Postpartum Myasthenic Crisis in a Patient with SLE: A Case Report and Literature Review
References
- Raut S, Reddy I, Sahi, Masood A, Malik BH. Association Between Systemic Lupus Erythematosus and Myasthenia Gravis: Coincidence or Sequelae? Cureus 2020 Jun 3;12(6):e8422.
- Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 2015;48(6):362-8.
- Mao ZF, Yang LX, Mo XA, Qin C, Lai YR, He NY, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci 2011 Mar;121(3):121-9.
- Hrycek A. Systemic lupus erythematosus and myasthenia gravis. Pol Arch Med Wewn 2009;119:582-5.
- Park MJ, Kim YA, Lee SS, Kim BC, Kim MK, Cho KH. Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports. J Korean Med Sci 2004; 19:134-6.
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 Apr;42(4):599-608.
- Sthoeger Z, Neiman A, Elbirt D, Zinger H, Magen E, Burstein R, et al. High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am J Med Sci 2006;331(1):4–9.
- Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989;80(4):290–5.
- Bekircan-Kurt CE, Tuncer Kurne A, Erdem-Ozdamar S, Kalyoncu U, Karabudak R, Tan E. The course of myasthenia gravis with systemic lupus erythematosus. Eur Neurol 2014;72(5-6):326-9.
- Jallouli M, Saadoun D, Eymard B, Leroux G, Haroche J, Le Thi Huong D, et al. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol 2012 Jul;259(7):1290-7.
- Nagarajan M, Maasila AT, Dhanapriya J, Dineshkumar T, Sakthirajan R, Rajasekar D, et al. Systemic Lupus Erythematosus and Myasthenia Gravis: A Rare Association. Indian J Nephrol 2019 Jan-Feb;29(1):62-4.
- Vaiopoulos G, Sfikakis PP, Kapsimali V, Boki K, Panayiotidis P, Aessopos A, et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J 1994;70:741–5.
- Barbosa RE, Córdova S, Cajigas JC. Coexistence of systemic lupus erythematosus and myasthenia gravis. Lupus 2000;9(2):156-7.
- Bhinder S, Majithia V, Harisdangkul V. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental-two case reports and review of the literature. Clin Rheumatol 2006 Jul;25(4):555-6.
- Castrejón I, Shum K, Tseng CE, Askanase A. Association between myasthaenia gravis and systemic lupus erythematosus: three case reports and review of the literature. Scand J Rheumatol 2011 Nov;40(6):486-90.
- Moulian N, Bidault J, Truffault F, Yamamoto AM, Levasseur P, Berrih-Aknin S. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 1997;89(9):3287–95.
- Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, et al. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol 2010 Jan;37(1):45-52.
- Shiao YM, Lee CC, Hsu YH, Huang SF, Lin CY, Li LH, et al. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia. J Neuroimmunol 2010 Apr 15;221(1-2):101-6.
- Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006;108:432-40.
- Sheng JR, Li L, Ganesh BB, Vasu C, Prabhakar BS, Meriggioli MN. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J Immunol 2006;177:5296-306.